Internal medicine

Pathology

Lymphoma

Waldenstrom macroglobulinemia

Intensive care medicine

Consensus conference

Medicine

The Lancet Haematology

Waldenström macroglobulinaemia is an indolent B-cell lymphoma with clearly defined criteria for diagnosis, initiation of therapy, and response, which was established by consensus panels at previous International Workshops for Waldenström Macroglobulinaemia (IWWM). The treatment options for Waldenström macroglobulinaemia continued to be researched after the publication of the eighth IWWM consensus recommendations in 2016, and at the tenth IWWM in New York, USA (October, 2018) an international consensus panel was formed to update treatment recommendations.

Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia